Resverlogix (TSE:RVX) Trading Up 16.7% – What’s Next?

by · The Cerbat Gem

Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price was up 16.7% on Wednesday . The stock traded as high as C$0.07 and last traded at C$0.07. Approximately 197,830 shares were traded during trading, an increase of 225% from the average daily volume of 60,927 shares. The stock had previously closed at C$0.06.

Resverlogix Stock Down 7.1 %

The firm has a 50 day moving average price of C$0.07 and a two-hundred day moving average price of C$0.06. The company has a market capitalization of C$18.00 million, a price-to-earnings ratio of -1.30 and a beta of 0.71.

Resverlogix (TSE:RVX – Get Free Report) last announced its earnings results on Wednesday, August 14th. The biotechnology company reported C($0.02) earnings per share for the quarter. Analysts predict that Resverlogix Corp. will post -0.22 earnings per share for the current year.

About Resverlogix

(Get Free Report)

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases.

Featured Articles